Yıl: 2005 Cilt: 35 Sayı: 1 Sayfa Aralığı: 5 - 12 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver

Öz:
The aim of this study was to investigate the toxic effects of the human immunodeficiency virus- reverse transcriptase (HIV-RT) inhibitor 2-phenoxymethyl-5-chlorobenzimidazole on rat liver at the light microscopic level to gain an insight into possible effects in human subjects. To do this, an animal experimental model was constructed and rats were divided into single injected rat (SIR) and multiple injected rat (MIR) groups, as well as single and multiple solvent dimethylsulfoxide (DMSO) injected controls and an untreated control. Cellular heterogeneity was observed in a non-prominent way in the SIR group (prominent in only one area) and very prominently in the perivenous areas in the MIR group. In almost all groups, the hepatocytes were lightly to moderately stained but were moderately to darkly stained in the MIR group, in addition to a propensity to be lighter in the periportal area. In the single solvent injected and the multiple solvent injected groups hepatocyte cytoplasms displayed a granular appearance, whereas in the experimental groups (SIR and MIR) both granular and patchy appearances were seen. In the multiple injected solvent and chemical groups, some hyaline-like material was seen within hepatocyte cytoplasms. In all groups perivenous hepatocyte nuclei were both normal and large but periportal ones were larger . Especially in the MIR group more nuclei were large in both areas. In each group lipid droplet-filled (differing in size) hepatocytes were present, especially in the perivenous area, but also in the periportal area although less prominently. More periportal hepatocytes contained lipid droplets in the MIR group. In all groups sinusoids were only slightly dilated especially peripherally in both regions. Endothelial cells were normal in all groups. They were usually undetectable in the MIR and multiple solvent injected groups, especially in the perivenous area whereas they seemed bulging towards the lumen in the SIR and single solvent injected groups. Kupffer cells were usually normal in morphology and number, but in the MIR and multiple solvent injected groups they were greater in number and displayed a bulging appearance. Also in the MIR group the number of Kupffer cells was higher. The space of Disse was normal in the multiple solvent injected group but was enlarged in the other groups. In almost all groups low to moderate amounts of lipid were seen within the dilated sinusoids, especially in the peripheral periportal area. The multiple solvent injected group displayed more lipid within the sinusoids. Bile canaliculi and ducts were normal in all groups. In the SIR and multiple solvent injected groups plasma cells and lymphocytes were seen within the connective tissue of the portal area, being more numerous in the multiple solvent injected group. The cellular toxic effects of 2-phenoxymethyl-5-chlorobenzimidazole on rat liver morphology should be further investigated at the subcellular and molecular levels.
Anahtar Kelime: Acquired Immunodeficiency Syndrome Dimethyl Sulfoxide Liver Models, Animal Rats, Wistar Toxic Actions Benzimidazoles

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Fishman JA. Treatment of infection due to pneumocystis carinii. Antimicrobial Agents and Chemotherapy; 42: 1309-1314,1998.
  • 2. Hof H. Critical annotations to the use of azole antifungals for plant protection. Antimicrobial Agents Chemother; 45:2987-2990,2001.
  • 3.Chiba N, von Zanten SJ, Sinclair P et al. Treating helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-helicobacter pylori positive ( CADET-Hp) randomised controlled trial. BMJ; 324:1012, 2002.
  • 4.Buerger I, Reefschlaeger J, Bender W et al. A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol: 75: 9077-9086, 2001.
  • 5. Adam RD. Biology of giardia lamblia. Clin Microbiol Rev;14: 447-475, 2001.
  • 6. Ridoux 0, Drancourt M. In vitro susceptibilities of the microsporidia encephalitozoon cuniculi, encephalitozoon hellem and encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites. Antimicrob Agents Chemother; 42: 3301-3303,1998.
  • 7. Morrissette NS, Sibley LD. Cytoskeleton of amplicomplexon parasites. Microbiol Mol Biol Rev; 66:21-38, 2002.
  • 8. Akbay A, Ören İ, Temiz-Arpacı Ö et al. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzthiazole and oxazolo (4,5-b) pyridine derivatives. Arzneim Forsch DrugRes; 53: 266-71, 2003.
  • 9. Yarpuzlu Akbay A, Yıldız I, Temiz Arpacı Ö et al. Adenosine deaminase inhibitor activity of some benzoxazole, benzimidazole and oxazolo ( 4,5-b) pyridine derivatives. XIII. BİYOTEKNOLOJİ KONGRESİ Bildiriler Kitabı. 25-29 Ağustos 2003 Çanakkale pp.21-26.
  • 10. Arterburn LM, Zurlo J, Yager JD, Overton RM, Heifetz AH. A morphological study of differentiated hepatocytes in vitro. Hepatology; 22: 175-187, 1995.
  • 11. Associated Intestinal Tract Organs, Part 25 Liver, pages: 575-591 in Histology for Pathologists, edited by Sternberg SS. Second edition, Lippincott-Raven Publishers , Philadelphia, 1997.
APA ULUTAŞ UĞUR Y, YARPUZLU A, NAZİKOĞLU A, AŞAN E, Yildiz I, KELEŞ Ş (2005). Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. , 5 - 12.
Chicago ULUTAŞ UĞUR YEŞİM,YARPUZLU Akbay Ayşegül,NAZİKOĞLU Ayşegül,AŞAN Esin,Yildiz Ilkay,KELEŞ Şükrü Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. (2005): 5 - 12.
MLA ULUTAŞ UĞUR YEŞİM,YARPUZLU Akbay Ayşegül,NAZİKOĞLU Ayşegül,AŞAN Esin,Yildiz Ilkay,KELEŞ Şükrü Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. , 2005, ss.5 - 12.
AMA ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. . 2005; 5 - 12.
Vancouver ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. . 2005; 5 - 12.
IEEE ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş "Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver." , ss.5 - 12, 2005.
ISNAD ULUTAŞ UĞUR, YEŞİM vd. "Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver". (2005), 5-12.
APA ULUTAŞ UĞUR Y, YARPUZLU A, NAZİKOĞLU A, AŞAN E, Yildiz I, KELEŞ Ş (2005). Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. Turkish Journal of Medical Sciences, 35(1), 5 - 12.
Chicago ULUTAŞ UĞUR YEŞİM,YARPUZLU Akbay Ayşegül,NAZİKOĞLU Ayşegül,AŞAN Esin,Yildiz Ilkay,KELEŞ Şükrü Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. Turkish Journal of Medical Sciences 35, no.1 (2005): 5 - 12.
MLA ULUTAŞ UĞUR YEŞİM,YARPUZLU Akbay Ayşegül,NAZİKOĞLU Ayşegül,AŞAN Esin,Yildiz Ilkay,KELEŞ Şükrü Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. Turkish Journal of Medical Sciences, vol.35, no.1, 2005, ss.5 - 12.
AMA ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. Turkish Journal of Medical Sciences. 2005; 35(1): 5 - 12.
Vancouver ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver. Turkish Journal of Medical Sciences. 2005; 35(1): 5 - 12.
IEEE ULUTAŞ UĞUR Y,YARPUZLU A,NAZİKOĞLU A,AŞAN E,Yildiz I,KELEŞ Ş "Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver." Turkish Journal of Medical Sciences, 35, ss.5 - 12, 2005.
ISNAD ULUTAŞ UĞUR, YEŞİM vd. "Investigating toxic effects of the HIV-RT inhibitor 2-phenoxymethyl-5-chloro-benzimidazole on rat liver". Turkish Journal of Medical Sciences 35/1 (2005), 5-12.